Armata Pharmaceuticals (ARMP) Return on Capital Employed (2016 - 2026)
Quarterly results put Return on Capital Employed at 58.07% for Q1 2026, down 22856.0% from a year ago — trailing twelve months through Mar 2026 was 58.07% (down 22856.0% YoY), and the annual figure for FY2025 was 50.38%, up 4573.0%.
Armata Pharmaceuticals has reported Return on Capital Employed over the past 13 years, most recently at 58.07% for Q1 2026.
- Return on Capital Employed reached 58.07% in Q1 2026 per ARMP's latest filing, down from 49.34% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 5801.9% in Q1 2024 and bottomed at 96.26% in Q4 2024.
- Median Return on Capital Employed over the past 5 years was 36.32% (2022), compared with a mean of 369.42%.
- The largest annual shift saw Return on Capital Employed skyrocketed 587955bps in 2024 before it plummeted -563141bps in 2025.
- Over 5 years, Return on Capital Employed stood at 53.17% in 2022, then rose by 14bps to 45.89% in 2023, then crashed by -110bps to 96.26% in 2024, then surged by 49bps to 49.34% in 2025, then dropped by -18bps to 58.07% in 2026.
- Business Quant data shows Return on Capital Employed for ARMP at 58.07% in Q1 2026, 49.34% in Q4 2025, and 60.86% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 21.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 10.19% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 20.34% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -58.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.07% |
| Dec 31, 2025 | -49.34% |
| Sep 30, 2025 | 60.86% |
| Jun 30, 2025 | 97.96% |
| Mar 31, 2025 | 170.49% |
| Dec 31, 2024 | -96.26% |
| Sep 30, 2024 | 277.83% |
| Jun 30, 2024 | 475.41% |
| Mar 31, 2024 | 5,801.90% |
| Dec 31, 2023 | -45.89% |
| Sep 30, 2023 | -48.93% |
| Jun 30, 2023 | -74.72% |
| Mar 31, 2023 | -77.65% |
| Dec 31, 2022 | -53.17% |
| Sep 30, 2022 | -36.32% |
| Jun 30, 2022 | -31.12% |
| Mar 31, 2022 | -32.91% |
| Dec 31, 2021 | -46.34% |
| Sep 30, 2021 | -60.23% |
| Jun 30, 2021 | -53.08% |
| Mar 31, 2021 | -53.64% |
| Dec 31, 2020 | -60.15% |
| Sep 30, 2020 | -48.18% |
| Jun 30, 2020 | -49.70% |
| Mar 31, 2020 | -74.71% |
| Dec 31, 2019 | -87.79% |
| Sep 30, 2019 | -66.94% |
| Jun 30, 2019 | -83.10% |
| Mar 31, 2019 | -135.54% |
| Dec 31, 2018 | -105.41% |
| Sep 30, 2018 | -122.83% |
| Jun 30, 2018 | -81.82% |
| Mar 31, 2018 | -144.19% |
| Dec 31, 2017 | -153.99% |
| Sep 30, 2017 | -214.39% |
| Jun 30, 2017 | -257.58% |
| Mar 31, 2017 | -166.42% |
| Dec 31, 2016 | -125.98% |
| Sep 30, 2016 | -58.99% |
| Jun 30, 2016 | -52.96% |